Calecim Professional

CALECIM® offers skin care and haircare backed by science, with proprietary active ingredient derived from ethically sourced stem cells.

In 2002, CellResearch Corporation (CALECIM®️Professional’s parent company) was founded. Two years later, they discovered the presence of stem cells within the umbilical cord lining of mammals, found that these stem cells were incredibly effective in skin repair and regeneration. Early research focused on chronic and hard-to-heal wounds, with the goal of creating approved drugs for indications such as Chronic Diabetic Wounds.

In 2016, CALECIM®️ Professional was born, a range of topical cosmetics. CALECIM®️ products contain PTT-6®️, which are the proteins, cytokines, growth factors and exosomes naturally secreted from umbilical cord lining stem cells. These work as messaging signals for skin cells that are in need of repair, such as after aesthetic treatments or as a result of aging. CALECIM®️ initially started by developing a range of products designed for post-procedure recovery, anti-aging and skin rejuvenation.

In 2021, after years of research and development by our scientists and trusted medical professionals, the CALECIM®️ Professional Advanced Hair System was launched. The product has undergone rigorous testing and has been shown to increase hair follicle cell proliferation by 24% and reduce inflammation by 30 times, the latter of which is the leading cause of hair loss. To date, the product has been used on thousands of people worldwide, with positive improvements in over 90% of clinical observations and zero reported side effects.

 

CellResearch Corporation is a biotechnology company with a primary focus on skin cell and cord lining stem cell research.  CellResearch has one of the world's largest private skin-, scar-, and keloid-cell libraries which have been used for research by cell culture laboratories worldwide, including those at Harvard University, Procter & Gamble and Johnson & Johnson. It owns 39 patents worldwide with intellectual property for the isolation of stem cells from the umbilical cord lining membrane of all mammals, which also includes the banking and cultivation of these cells, as well as the therapeutic applications of these cells.